Dulaglutide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1263 publications

Comment on Ostrominski et al. Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.

Comment on Ostrominski et al. Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.

Journal: Diabetes care

Published: August 20, 2026

Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis.

Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis.

Journal: Foot & ankle specialist

Published: August 18, 2026

Glucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions.

Glucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions.

Journal: Clinics in dermatology

Published: August 14, 2026

Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia.

Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia.

Journal: The Journal of international medical research

Published: August 08, 2026

Incorporating estimands into meta-analyses of clinical trials.

Incorporating estimands into meta-analyses of clinical trials.

Journal: Research synthesis methods

Published: July 30, 2026

The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity.

The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity.

Journal: Pharmacological research

Published: July 27, 2026

Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.

Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.

Journal: Diabetes, obesity & metabolism

Published: July 14, 2026

Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.

Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.

Journal: Annals of internal medicine

Published: July 13, 2026

Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs: A Systematic Review and Pairwise Meta-Analysis.

Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs: A Systematic Review and Pairwise Meta-Analysis.

Journal: Cureus

Published: June 23, 2026

Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.

Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.

Journal: The American journal of managed care

Published: June 23, 2026

Changes in recorded background glucose-lowering therapy after initiation of a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist in adults with type 2 diabetes.

Changes in recorded background glucose-lowering therapy after initiation of a GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist in adults with type 2 diabetes.

Journal: Diabetes research and clinical practice

Published: June 22, 2026

Differential Protective Actions of Dulaglutide and Dexamethasone in Methotrexate Induced Pulmonary Fibrosis: Relationship with AMPK and Beclin-1 Levels.

Differential Protective Actions of Dulaglutide and Dexamethasone in Methotrexate Induced Pulmonary Fibrosis: Relationship with AMPK and Beclin-1 Levels.

Journal: Biomedicines

Published: June 20, 2026

Showing 1-12 of 1,263

Last Updated: 09/26/2026